In patients with advanced chronic kidney disease (CKD) and diabetes, treatment with rilparencel resulted in statistically significant and clinically meaningful slowing of CKD progressionBilateral ...
Donald Trump may see the filibuster as a wall in his way. In truth, it is the last wall standing between the country and ...
ProKidney (PROK) presented full results from the Phase 2 REGEN-007 trial evaluating rilparencel in patients with advanced CKD and diabetes. The ...
Co-founded by CPA Parker Moffat and entrepreneur Nate Nead, the new platform helps small business owners move beyond simple tax filing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback